Topcare Lice Killing Creme Rinse

For the treatment of scabies in adults, the standard protocol involves the application of Permethrin 5% cream. A single application is usually sufficient to clear the infestation, although a second application 7 to 14 days later is often recommended to ensure any newly hatched mites are destroyed. Adults typically require approximately 30 grams (one full tube) to cover the entire body from the neck down to the soles of the feet.

For head lice, adults should use Permethrin 1% lotion. After washing the hair with a regular shampoo (without conditioner) and towel-drying it, a sufficient amount of the lotion should be applied to saturate the hair and scalp, especially behind the ears and at the nape of the neck. The product is left in place for 10 minutes and then rinsed thoroughly with warm water.

Permethrin is generally considered safe for children, but the dosage must be carefully managed based on age.

• Infants (2 months to 2 years): For scabies, the 5% cream should be applied to the entire body, including the face, scalp, and forehead, as infants often have infestations in these areas. Care must be taken to avoid the eyes and mouth. Use only under strict medical supervision.
• Children (2 years and older): The dosage for scabies is similar to adults, though less cream may be needed to cover their smaller body surface area. For head lice, the 1% lotion is used identically to the adult protocol.
• Infants under 2 months: Permethrin is NOT typically approved for use in infants under 2 months of age. Safety and efficacy have not been established in this population.

Renal Impairment

Because systemic absorption of topical permethrin is less than 2%, dose adjustments for patients with kidney disease are generally not required. The kidneys process the inactive metabolites, and the low concentrations do not typically pose a risk of accumulation.

Hepatic Impairment

Similar to renal impairment, the minimal systemic absorption means that dose adjustments for liver disease are usually unnecessary. However, patients with severe hepatic failure should be monitored for any unusual systemic reactions.

Elderly Patients

Elderly patients can use standard dosages. However, healthcare providers may advise caution if the patient has very thin or fragile skin, as this could theoretically increase the amount of drug absorbed into the bloodstream.

Permethrin is for external use only. It should never be swallowed or applied to mucous membranes.

1. 1Preparation: For scabies, ensure the skin is clean, cool, and dry. Do not take a hot bath immediately before application, as this can increase systemic absorption by dilating blood vessels in the skin.
2. 2Application: Massage the cream thoroughly into the skin from the neck to the soles of the feet. Pay special attention to skin folds, such as between the fingers and toes, under the fingernails, the armpits, and the groin area.
3. 3Duration: Leave the cream on for 8 to 14 hours. Most patients apply it before bed and wash it off in the morning.
4. 4Removal: Wash the cream off completely in the shower or bath using warm, soapy water.
5. 5Environment: To prevent re-infestation, all recently worn clothing, bed linens, and towels must be washed in hot water (at least 130°F or 60°C) and dried on high heat.

Since permethrin is usually a one-time or two-time application, a "missed dose" is rare. If you forget to apply it at the scheduled time, apply it as soon as you remember. If you were supposed to apply a second treatment a week later and forgot, apply it as soon as possible to ensure the life cycle of the parasite is broken.

Signs of a topical overdose are rare but may include severe skin irritation, swelling, or redness. If the medication is accidentally swallowed, symptoms may include nausea, vomiting, dizziness, and abdominal pain. In the event of accidental ingestion, contact a Poison Control Center or seek emergency medical attention immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or re-apply the medication more frequently than directed, as this increases the risk of skin irritation without improving the cure rate.

The most frequently reported side effects of permethrin are localized to the site of application. Because the drug is used to treat conditions that are inherently itchy, it can be difficult to distinguish between the symptoms of the infestation and the side effects of the medication.

• Pruritus (Itching): Many patients experience an increase in itching immediately after application. This is often a reaction to the mites dying or a mild irritation from the cream itself. This itching can persist for several weeks even after the mites are dead.
• Erythema (Redness): Mild redness of the skin is common and usually fades within 24 hours of washing the medication off.
• Stinging or Burning: A transient stinging or burning sensation may occur shortly after the cream or lotion is applied, particularly if the skin has been scratched raw prior to treatment.

• Edema (Swelling): Some patients may notice slight swelling in the areas where the cream was applied.
• Paresthesia (Numbness or Tingling): A "pins and needles" sensation or localized numbness can occur. This is usually temporary and resolves once the product is rinsed away.
• Rash Expansion: The pre-existing rash may appear to worsen slightly before it begins to heal.

• Contact Dermatitis: A localized allergic reaction characterized by blisters, oozing, or severe crusting of the skin.
• Dizziness: Although systemic absorption is low, some patients have reported mild lightheadedness.
• Abdominal Pain: Extremely rare and usually associated with accidental ingestion or excessive application over large areas of broken skin.

> Warning: Stop using Permethrin and call your doctor immediately if you experience any of these serious reactions.

• Anaphylaxis (Severe Allergic Reaction): Symptoms include hives, difficulty breathing, swelling of the face, lips, tongue, or throat, and a rapid heartbeat. This is a medical emergency.
• Severe Chemical Burns: If the skin becomes intensely painful, turns white, or begins to peel excessively, rinse the area immediately and seek medical help.
• Seizures: While extremely rare and typically only seen in cases of significant ingestion, any neurological changes require immediate evaluation.
• Severe Bronchospasm: Patients with a history of asthma may experience wheezing or chest tightness if they inhale the vapors of the product.

Permethrin is not intended for long-term or chronic use. However, repeated, unnecessary applications can lead to:

• Chronic Skin Irritation: The skin's natural barrier can become compromised, leading to persistent dryness and sensitivity.
• Parasitic Resistance: Overuse of permethrin has led to the emergence of "super lice" in many parts of the world. These are lice populations that have developed genetic mutations making them less susceptible to the neurotoxic effects of pyrethroids.
• Post-Scabietic Itch: This is not a direct side effect of the drug but a prolonged immunological reaction to the dead mites and their waste products. It can last for 4-6 weeks after successful treatment and may require topical steroids for relief.

No FDA black box warnings for Permethrin. It is generally recognized as safe when used as directed for its narrow range of indications.

Report any unusual symptoms or persistent skin changes to your healthcare provider. If the itching does not resolve within four weeks of treatment, a follow-up with a dermatologist is necessary to confirm the mites have been eradicated.

Permethrin is intended for topical use only. It is a powerful chemical that must be handled with care. Patients should ensure that the medication does not come into contact with the eyes, nose, mouth, or vagina. If contact occurs, the area should be flushed immediately with large amounts of water. Additionally, permethrin is highly toxic to certain household pets, particularly cats. Cats lack the liver enzyme (glucuronosyltransferase) required to metabolize permethrin; contact with even small amounts of the 5% cream can be fatal to a cat. If you have cats, keep them away from treated individuals until the medication has been washed off.

No FDA black box warnings for Permethrin. The safety profile is well-established for the approved indications of lice and scabies treatment in both adults and children over two months of age.

• Allergic Reactions / Anaphylaxis Risk: Patients with a known allergy to pyrethrins or pyrethroids should not use permethrin. Furthermore, there is a theoretical risk of cross-sensitivity for individuals allergic to chrysanthemums or ragweed. If you have severe seasonal allergies, discuss this with your doctor before use.
• Asthma and Respiratory Conditions: While permethrin is applied to the skin, the vapors from the 1% lotion or 5% cream can trigger respiratory distress in sensitive individuals. Application should occur in a well-ventilated room.
• Skin Integrity: Permethrin should not be applied to skin that is severely infected, bleeding, or has open wounds unless specifically directed by a physician. Damaged skin can significantly increase the amount of the drug that enters the bloodstream.
• Secondary Infections: Scabies and lice often lead to intense scratching, which can break the skin and cause secondary bacterial infections (like impetigo). Permethrin treats the parasites but will not treat a bacterial infection; antibiotics may be needed concurrently.

There are no standard laboratory tests (like blood counts or liver panels) required for the use of permethrin due to its low systemic absorption. However, clinical monitoring is essential:

• Treatment Success: Patients should be monitored for the appearance of new burrows or lice. If live mites or lice are seen 7-14 days after the initial treatment, a second application is usually necessary.
• Skin Sensitivity: Regular inspection of the treated area for signs of contact dermatitis or severe irritation is recommended.

Permethrin does not typically affect the ability to drive or operate heavy machinery. Because systemic levels are so low, it does not cause drowsiness or impairment of motor skills.

There are no known direct interactions between topical permethrin and alcohol consumption. However, alcohol can cause vasodilation (widening of blood vessels), which might theoretically increase skin sensitivity or itching during treatment.

Permethrin is used as a short-term pulse therapy. There are no withdrawal syndromes associated with stopping its use. If treatment is discontinued before the parasites are fully eradicated, the infestation will likely return and may spread to other household members.

> Important: Discuss all your medical conditions, especially any history of skin sensitivity or respiratory issues, with your healthcare provider before starting Permethrin.

There are no documented "never-use" drug combinations for topical permethrin due to its minimal systemic absorption. However, it should not be used simultaneously with other topical scabicides or pediculicides (such as lindane or malathion) unless specifically instructed by a specialist, as this can lead to severe skin toxicity and irritation without increasing the efficacy of the treatment.

• Topical Corticosteroids: If a patient is using high-potency topical steroids (like clobetasol) for another skin condition, the steroid may mask the inflammatory response to the scabies mite. This can lead to a "scabies incognito" situation where the infestation continues to spread because the itching is suppressed. Healthcare providers usually recommend stopping steroids during the active treatment phase of permethrin.
• Skin Barrier Disruptors: Products containing high concentrations of salicylic acid, urea, or alpha-hydroxy acids can thin the stratum corneum (the outermost layer of skin). Using these products immediately before or during permethrin treatment may increase the systemic absorption of the neurotoxin, potentially leading to systemic side effects.

• Other Topical Medications: Any cream, lotion, or ointment applied to the same area of skin may interfere with the ability of permethrin to bind to the parasite. It is best to apply permethrin to clean skin that is free of other products.
• Moisturizers and Oils: Applying heavy oils or moisturizers before permethrin can create a barrier that prevents the drug from reaching the mites or lice effectively. Use these only after the permethrin has been washed off.

There are no known food interactions with topical permethrin. Unlike oral medications, the absorption of permethrin is not affected by the consumption of grapefruit, dairy, or high-fat meals.

There are no documented interactions between topical permethrin and common herbal supplements like St. John's Wort or Ginkgo Biloba. Because the drug does not significantly enter the bloodstream, it does not interact with the hepatic enzymes that typically cause supplement-drug interactions.

Permethrin does not interfere with standard blood or urine laboratory tests. It does not cause false positives on drug screenings or affect glucose, cholesterol, or electrolyte readings.

Mechanism of Interaction

Most interactions with permethrin are pharmacodynamic in nature, meaning they occur at the site of action (the skin). For example, the interaction with corticosteroids is pharmacodynamic because the steroid changes the body's immune response to the parasite, not the concentration of the permethrin itself. Pharmacokinetic interactions (changes in how the body processes the drug) are rare and would only occur if the skin barrier is so compromised that systemic absorption reaches levels high enough to interact with liver enzymes.

Management Strategy

To minimize interaction risks:

1. 1Apply permethrin to clean, dry skin.
2. 2Avoid other topical products for 24 hours before and after treatment.
3. 3Inform your doctor of all skin products you use, including cosmetic lotions.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, even if they are only applied to the skin.

There are several conditions where permethrin must NEVER be used because the risks far outweigh any potential benefits:

1. 1Hypersensitivity to Permethrin: If a patient has had a prior allergic reaction to permethrin, including rash, hives, or difficulty breathing, the drug is absolutely contraindicated. Re-exposure can lead to life-threatening anaphylaxis.
2. 2Hypersensitivity to Synthetic Pyrethroids: Because permethrin is a member of the pyrethroid family, an allergy to related chemicals (such as cypermethrin or deltamethrin) precludes its use.
3. 3Hypersensitivity to Pyrethrins: Pyrethrins are the natural precursors to permethrin. A known allergy to these natural extracts indicates a high risk of cross-reactivity.

These are conditions that require a careful risk-benefit analysis by a healthcare provider:

• Infants under 2 months of age: The skin of newborns is much thinner and more permeable than that of older children, and their metabolic pathways for breaking down the drug are not fully developed. Use in this age group is generally avoided unless no other options exist and it is done under hospital supervision.
• Pregnancy and Breastfeeding: While generally considered safe (Category B), it should only be used if the infestation poses a significant health risk to the mother or infant.
• Extensive Broken Skin: If the patient has severe, weeping eczema or widespread skin breakdown from scratching, the risk of systemic absorption increases. A doctor may choose to treat the skin infection first before applying permethrin.
• Ragweed Allergy: There is a long-standing clinical debate regarding cross-sensitivity between ragweed/chrysanthemums and permethrin. While the risk is low, patients with severe ragweed allergies should be monitored closely for signs of a reaction.

Cross-sensitivity occurs when the immune system reacts to a drug because it is chemically similar to another substance the person is allergic to. For permethrin, cross-sensitivity is most common with:

• Pyrethrum-containing insecticides (used in gardening or pet shampoos).
• Chrysanthemum flowers.
• Ragweed pollen (less common but possible).

> Important: Your healthcare provider will evaluate your complete medical history and allergy profile before prescribing Permethrin to ensure it is safe for you.

Permethrin is classified as FDA Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. Because systemic absorption is so low (less than 2%), the amount of drug that could potentially reach the developing fetus is considered negligible. Most clinical guidelines suggest that permethrin is the preferred treatment for scabies during pregnancy when treatment is necessary. However, it should only be used under the direction of a physician, particularly during the first trimester.

It is not known whether permethrin is excreted in human breast milk. However, because systemic levels in the mother's blood are extremely low, the amount that could pass into milk is likely insignificant. The primary concern during breastfeeding is the infant's direct skin contact with the treated areas of the mother's body. If the mother is being treated for scabies, she should thoroughly wash the cream off her breasts before nursing to prevent the infant from ingesting the medication or having it touch their sensitive skin.

Permethrin is widely used in children. For head lice, it is approved for children as young as 2 months of age. For scabies, the 5% cream is also approved for infants 2 months and older. In pediatric patients, it is vital to prevent the child from licking the cream or getting it into their eyes. Parents are often advised to put mittens or socks on an infant's hands after application to prevent them from sucking on their fingers and ingesting the drug.

Clinical studies of permethrin did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious. The skin of older adults is often thinner and drier, which may lead to increased irritation. Furthermore, elderly patients in long-term care facilities are at higher risk for "crusted scabies" (Norwegian scabies), a severe form of the infestation that may require multiple treatments and oral medications in addition to permethrin.

No dosage adjustments are provided in the manufacturer's labeling for patients with renal impairment. The tiny fraction of the drug that is absorbed is converted into inactive metabolites before being cleared by the kidneys, making it safe for most patients with kidney disease.

No dosage adjustments are required for patients with liver disease. While the liver is responsible for metabolizing the small amount of absorbed permethrin, the total quantity is so low that even a compromised liver can typically process it without difficulty.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or nursing before using this medication.

Permethrin is a neuronal sodium channel modulator. In parasites, it acts on the nerve cell membranes to disrupt the sodium channel current by which the polarization of the membrane is regulated. Specifically, it binds to the alpha-subunit of the voltage-gated sodium channels. By delaying the closing (inactivation) of these channels, permethrin causes a state of hyperexcitability in the parasite's nervous system. This results in spontaneous firing of neurons, followed by muscular tetany (sustained contraction) and eventual functional paralysis. Because the respiratory muscles of the lice or mites are affected, the parasites die of asphyxiation or exhaustion.

The pharmacodynamic effect of permethrin is rapid, often referred to as the "knockdown effect." Upon contact with the 1% or 5% concentration, the parasite's movement is inhibited within minutes. However, the drug is primarily a killing agent (pediculicidal/scabicidal) rather than an egg-killing agent (ovicidal). While it may kill some eggs, many eggs remain viable, which is why a second application is often required to kill the nymphs that hatch after the first treatment. There is no evidence of the development of tolerance within a single treatment course, though genetic resistance in lice populations is a growing global concern.

| Parameter | Value |

|---|---|

| Bioavailability | < 2% (Topical) |

| Protein Binding | Highly bound in plasma (though systemic levels are negligible) |

| Half-life | 8-12 hours (Skin clearance) |

| Tmax | Not applicable (Topical) |

| Metabolism | Hepatic ester hydrolysis to inactive metabolites |

| Excretion | Renal (>90% of absorbed dose) |

• Molecular Formula: C21H20Cl2O3
• Molecular Weight: 391.29 g/mol
• Solubility: Highly lipophilic (fat-soluble); insoluble in water; soluble in non-polar organic solvents.
• Structure: Permethrin is a mixture of cis and trans isomers. The trans isomer is generally less toxic to mammals than the cis isomer. Most pharmaceutical preparations maintain a specific cis:trans ratio (typically 25:75 or 40:60) to maximize parasite toxicity while minimizing human risk.

Permethrin is a synthetic pyrethroid. It is categorized as an ectoparasiticide. Related medications in this class include pyrethrins (the natural version) and other synthetic variants like phenothrin, though permethrin remains the most widely used in clinical medicine.